Cheshire & Merseyside Cancer Alliance deploys Bestoutcome’s PM3 tool
Category : #Business  By- Puja More  Date: 2020-11-04
  • share
  • Twitter
  • Facebook
  • LinkedIn
Cheshire & Merseyside Cancer Alliance deploys Bestoutcome’s PM3 tool

Cheshire and Merseyside Cancer Alliance (NHS) has selected project portfolio management software leader, Bestoutcome, for its project, programme, and portfolio management. Following the assessment of leading PPM packages in the market, CMCA has finally settled on the company’s PM3.

As expressed by PMO Manager, Sarah Atherden, the alliance has selected PM3 due to its extensive utility in the NHS, its ease of usage and efficient and powerful reporting mechanisms. Even though NHS has some sound project management practices across the CMCA, it wanted to have a more consistent and standardized approach which could be supported and facilitated via PM3.

The tool’s capability of partitioning will enable every partner within the Alliance to keep their projects private, allowing various organizations to work on collaborated programmes that suit their requirements, added Atherden.

Reportedly, Cheshire and Merseyside Cancer Alliance stands at the forefront of the execution of NHS’s LTP (Long Term Plan) ambitions for cancer across its local system and also offers co-ordination and system oversight for cancer services via collaborative agreements with partners. The alliance has the objective of enhancing patient outcomes and improving performance against key operational standards, cite sources.

With regards to this deployment, Bestoutcome Director, David Walton, has expressed the company’s pleasure in having been chosen by Cheshire and Merseyside Cancer Alliance for helping to manage its programmes and projects. PM3 was apparently selected for helping to furnish a standardized approach to project management and to deliver a ‘single source of the Truth’ that would support visibility and consistency across programmes for all aspects of reporting.

Uninitiated, Bestoutcome is renowned for its tools in project, programme, and portfolio management services and always concentrates on the total outcome for ensuring successful business change. The company’s flagship PPM tool, PM3, is being deployed by a broad set of clients in the public, private, and charity sectors, state sources.

 

Source Credits:

http://www.prweb.com/releases/cheshire_and_merseyside_cancer_alliance_nhs_select_pm3_as_their_ppm_tool/prweb17510576.htm

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Puja More    

Puja More

Puja More holds a graduate degree in Computer Science from the University of Pune. Nurturing her passion of playing with words however, Puja undertook content writing as a career path and boasts of rich experience in content production, copywriting, and digital market...

Read More

Most Read

Biohaven, Sosei Heptares ink deal on small-molecule CGRP antagonists
Biohaven, Sosei Heptares ink deal on small-molecule CGRP antagonists
By- Puja More  Date: 2020-12-03

Biohaven Pharmaceutical Holding Company and Sosei Group Corporation have signed a collaboration and licensing agreement under which the form...

Cerus receives FDA nod for INTERCEPT Blood System for Cryoprecipitation
Cerus receives FDA nod for INTERCEPT Blood System for Cryoprecipitation
By- Madhura Dethe  Date: 2020-12-02

Adding to yet other initiatives and accomplishments in the medical fraternity, a California-based pathogen-protected blood component develop...

Nigeria set to commence installation of 5Mn solar home power systems
Nigeria set to commence installation of 5Mn solar home power systems
By- Puja More  Date: 2020-12-01

The first phase of installation is expected to be commenced in December 2020 nationwide. The Federal Government of Nigeria has recently sta...

Ascentage partners with U-M to attain license for a MDM2 degrader
Ascentage partners with U-M to attain license for a MDM2 degrader
By- Puja More  Date: 2020-11-30

Acquisitions, collaborations, and mergers have become a common practice in the medical and biotechnology sector in recent years. Speaking of...

Our Conrtributor

Apple launches ‘AirPods Max’, its first over-ear headphones at $550

Apple launches ‘AirPods Max’, its first over-ear headphones at $550

By- Puja More

Technology giant- Apple Inc. has recently unveiled the ‘AirPods Max’, active noise-cance...

Zydus receives DGCI approval for Phase-1 clinical trial of ZYIL1

Zydus receives DGCI approval for Phase-1 clinical trial of ZYIL1

By- Puja More

ZYIL1 stands out to be a novel oral small molecule NLRP3 inhibitor candidate which is expected to be...

Gupshup to better business communications, launches GIP for the same

Gupshup to better business communications, launches GIP for the same

By- Puja More

Messaging services company, Gupshup has reportedly launched an all-new IP-based messaging channel wi...